InspireMD Reports First Quarter 2025 Financial Results
Provided By GlobeNewswire
Last update: May 9, 2025
MIAMI, May 09, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced financial and operating results for the first quarter ended March 31, 2025.
Read more at globenewswire.com
